Usha G. Mallya

1.4k total citations
50 papers, 1.0k citations indexed

About

Usha G. Mallya is a scholar working on Dermatology, Economics and Econometrics and Rheumatology. According to data from OpenAlex, Usha G. Mallya has authored 50 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Dermatology, 12 papers in Economics and Econometrics and 10 papers in Rheumatology. Recurrent topics in Usha G. Mallya's work include Dermatology and Skin Diseases (12 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Lipoproteins and Cardiovascular Health (8 papers). Usha G. Mallya is often cited by papers focused on Dermatology and Skin Diseases (12 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Lipoproteins and Cardiovascular Health (8 papers). Usha G. Mallya collaborates with scholars based in United States, United Kingdom and Switzerland. Usha G. Mallya's co-authors include David P. Nau, Abhijit Gadkari, Steven R. Feldman, Robert J. Sanchez, Mary Panaccio, Andrew Koren, Chakkarin Burudpakdee, Dong‐Churl Suh, Rajesh Pahwa and Ellen Bishop and has published in prestigious journals such as PLoS ONE, The American Journal of Medicine and The American Journal of Cardiology.

In The Last Decade

Usha G. Mallya

49 papers receiving 1.0k citations

Peers

Usha G. Mallya

DERMA

SURGE

PHYSI

Alejandro Arana United States

Cathy Zhao Australia

Shiraz R. Gupta United States

Kadir Yıldırım Türkiye

W Lorenz Germany

Del Giacco Gs Italy

Emmilia A. Dowlatshahi Netherlands

Despoina Manousaki Canada

Liyun He China

Alejandro Arana United States

Usha G. Mallya

290 ×0.9

DERMA

210 ×0.9

82 ×0.4

SURGE

54 ×0.3

106 ×0.6

PHYSI

Citations per year, relative to Usha G. Mallya Usha G. Mallya (= 1×) peers Alejandro Arana

Countries citing papers authored by Usha G. Mallya

Since Specialization

Citations

This map shows the geographic impact of Usha G. Mallya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Usha G. Mallya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Usha G. Mallya more than expected).

Fields of papers citing papers by Usha G. Mallya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Usha G. Mallya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Usha G. Mallya. The network helps show where Usha G. Mallya may publish in the future.

Co-authorship network of co-authors of Usha G. Mallya

This figure shows the co-authorship network connecting the top 25 collaborators of Usha G. Mallya. A scholar is included among the top collaborators of Usha G. Mallya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Usha G. Mallya. Usha G. Mallya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mallya, Usha G., Sheri Fehnel, Robert S. Mittleman, et al.. (2023). Interview-Based Patient- and Caregiver-Reported Experiences of Hunger and Improved Quality of Life with Setmelanotide Treatment in Bardet-Biedl Syndrome. Advances in Therapy. 40(5). 2394–2411. 14 indexed citations

Forsythe, Elizabeth, Usha G. Mallya, Min Yang, et al.. (2023). Burden of hyperphagia and obesity in Bardet–Biedl syndrome: a multicountry survey. Orphanet Journal of Rare Diseases. 18(1). 182–182. 15 indexed citations

Matza, Louis S., et al.. (2022). Health state utilities associated with hyperphagia: Data for use in cost‐utility models. Obesity Science & Practice. 9(4). 376–382. 2 indexed citations

Wabitsch, Martin, I. Sadaf Farooqi, Christa E. Flück, et al.. (2022). Natural History of Obesity Due to POMC, PCSK1, and LEPR Deficiency and the Impact of Setmelanotide. Journal of the Endocrine Society. 6(6). bvac057–bvac057. 40 indexed citations

Wabitsch, Martin, Sheri Fehnel, Usha G. Mallya, et al.. (2022). Understanding the Patient Experience of Hunger and Improved Quality of Life with Setmelanotide Treatment in POMC and LEPR Deficiencies. Advances in Therapy. 39(4). 1772–1783. 22 indexed citations

Eichenfield, Lawrence F., April W. Armstrong, Emma Guttman‐Yassky, et al.. (2022). Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset. Dermatology and Therapy. 12(6). 1337–1350. 6 indexed citations

Paller, Amy S., Paola Mina‐Osorio, Francis Vekeman, et al.. (2021). Prevalence of type 2 inflammatory diseases in pediatric patients with atopic dermatitis: Real-world evidence. Journal of the American Academy of Dermatology. 86(4). 758–765. 8 indexed citations

Siegfried, Elaine C., Amy S. Paller, Paola Mina‐Osorio, et al.. (2020). Effects of variations in access to care for children with atopic dermatitis. BMC Dermatology. 20(1). 24–24. 28 indexed citations

Silverberg, Jonathan I., Emma Guttman‐Yassky, A. Gadkari, et al.. (2019). 673 Real-world persistence with dupilumab among adults with atopic dermatitis (AD). Journal of Investigative Dermatology. 139(5). S116–S116. 1 indexed citations

10.

Fournier, Marie, Chieh-I Chen, Andreas Kuznik, et al.. (2019). <p>Sarilumab monotherapy compared with adalimumab monotherapy for the treatment of moderately to severely active rheumatoid arthritis: an analysis of incremental cost per effectively treated patient</p>. ClinicoEconomics and Outcomes Research. Volume 11. 117–128. 7 indexed citations

11.

Karalis, Dean G., Usha G. Mallya, Ameen Ghannam, et al.. (2018). Prescribing Patterns of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in Eligible Patients With Clinical Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia. The American Journal of Cardiology. 121(10). 1155–1161. 24 indexed citations

12.

Go, Alan S., Dongjie Fan, Sue Hee Sung, et al.. (2017). Contemporary rates and correlates of statin use and adherence in nondiabetic adults with cardiovascular risk factors: The KP CHAMP study. American Heart Journal. 194. 25–38. 11 indexed citations

13.

Schulman, Kathy L., Lois Lamerato, Mehul Dalal, et al.. (2016). Development and Validation of Algorithms to Identify Statin Intolerance in a US Administrative Database. Value in Health. 19(6). 852–860. 12 indexed citations

14.

Feldman, Steven R., et al.. (2014). The economic burden of psoriasis: a systematic literature review. Expert Review of Pharmacoeconomics & Outcomes Research. 14(5). 685–705. 65 indexed citations

15.

Strand, Vibeke, Mark Kosinski, Ari Gnanasakthy, Usha G. Mallya, & Shephard Mpofu. (2014). Secukinumab treatment in rheumatoid arthritis is associated with incremental benefit in the clinical outcomes and HRQoL improvements that exceed minimally important thresholds. Health and Quality of Life Outcomes. 12(1). 31–31. 19 indexed citations

16.

Sullivan, Sean D., Rafael Alfonso‐Cristancho, Josh J. Carlson, Usha G. Mallya, & Sarah Ringold. (2013). Economic consequences of sequencing biologics in rheumatoid arthritis: a systematic review. Journal of Medical Economics. 16(3). 391–396. 26 indexed citations

17.

Strober, Bruce, Judit Nyirady, Usha G. Mallya, et al.. (2013). Item-Level Psychometric Properties for a New Patient-Reported Psoriasis Symptom Diary. Value in Health. 16(6). 1014–1022. 22 indexed citations

18.

Kosinski, Mark, Jakob Bue Bjørner, Ari Gnanasakthy, Usha G. Mallya, & Shephard Mpofu. (2013). Applying Item Response Theory Methods to Improve the Measurement of Fatigue in a Clinical Trial of Rheumatoid Arthritis Patients Treated with Secukinumab*. 3(4). 192–201. 1 indexed citations

19.

Suh, Dong‐Churl, Rajesh Pahwa, & Usha G. Mallya. (2012). Treatment patterns and associated costs with Parkinson's disease levodopa induced dyskinesia. Journal of the Neurological Sciences. 319(1-2). 24–31. 36 indexed citations

20.

Nau, David P. & Usha G. Mallya. (2005). Sex disparity in the management of dyslipidemia among patients with type 2 diabetes mellitus in a managed care organization.. PubMed. 11(2). 69–73. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact